Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
15 March 2019 | Story Rulanzen Martin | Photo Rulanzen Martin
IAC members
The IAC from left; Dr Ivor Zwane, Reneë Beck, Gus Silber, Luhlumelo Toyana, Dr Adri van der Merwe, Nick Efstathiou, Avela Ntsongelwa, Prof Colin Chasi, HOD Communication Department, Alzane Narrain, Nomvo Bam and Dr Gustav Puth.

Building ties with industry experts provides greater prospects for bursaries, prizes for top students, as well as informal internships. This is why the Department of Communication Science at the University of the Free State (UFS) took the bold and commendable step of soliciting the expertise of an Industry Advisory Council (IAC).

“As a department we believe it is important to stay in touch with the industry to ensure that we, and the work we do, stays relevant in order to increase the chances of making our students preferred candidates in the workplace,” said Dr Adri van der Merwe, lecturer at the department.

The advisory panel consisted of Reneë Beck, founder and CEO of Pink Lemon; Nick Efstathiou, newly appointed CEO of Central Media Group; DDr Ivor Zwane, chairman of the board for Small to Medium Enterprise Development; education journalist Gus Silber; journalist Alzane Narrain; Dr Gustav Puth, Academic Director of Post-Graduate Executive Education at Monash South Africa; photographer Luhlumelo Toyana; Avela Ntsongelwa,master's student and Nomvo Bam.

The initiative also created a platform for the students to engage with IAC members. The Department hosted the IAC on 6 March 2019 on the UFS Bloemfontein Campus.

Advice to assist in improving curriculum

“The IAC members’ feedback will influence our curriculum, both in the short term when we begin to shift emphasis on certain matters, as well as in the longer term when we replace or expand on specific modules,” Van der Merwe said.

The advice given by IAC members will be taken very seriously. “We have captured all their input on video, and will now, in preparation for our strategic planning session later this year, analyse and prioritise the actions we need to implement their proposals.” she said. The students are also represented on the IAC in order to hear and take into consideration what the students have to say about how the curriculum can be improved to prepare them more effectively for the workplace. 

The department plan on hosting the IAC yearly.

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept